[Entering of patients in clinical-oncological trials: why not exclusive exclusion when inclusion is out of the question?]

Ned Tijdschr Geneeskd. 1995 May 20;139(20):1053-4.
[Article in Dutch]
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Clinical Trials, Phase III as Topic*
  • Female
  • Humans
  • Patient Selection*